Termination of second trimester pregnancy with intra-amniotic administration of prostaglandins E 2  and F 2  .
D000032:Abortion, Therapeutic; D000653:Amniotic Fluid; D000818:Animals; D004305:Dose-Response Relationship, Drug; D005069:Evaluation Studies as Topic; D005260:Female; D005334:Fever / Q000139:chemically induced; D005500:Follow-Up Studies; D000882:Haplorhini; D006261:Headache / Q000139:chemically induced; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D010215:Papio; D011247:Pregnancy; D011453:Prostaglandins / Q000008:administration & dosage* / Q000009:adverse effects; D001743:Urinary Bladder / Q000187:drug effects; D014839:Vomiting / Q000139:chemically induced
D011453:Prostaglandins